| Id |
Subject |
Object |
Predicate |
Lexical cue |
| TextSentencer_T1 |
0-59 |
Sentence |
denotes |
Metabolic clearance rate of dehydroisoandrosterone sulfate. |
| TextSentencer_T2 |
60-62 |
Sentence |
denotes |
V. |
| TextSentencer_T3 |
63-120 |
Sentence |
denotes |
Studies of essential hypertension complicating pregnancy. |
| TextSentencer_T4 |
121-281 |
Sentence |
denotes |
The metabolic clearance rate of dehydroisoandrosterone sulfate (MCRDS) was determined prospectively in gravidas with and without chronic essential hypertension. |
| TextSentencer_T5 |
282-367 |
Sentence |
denotes |
In normotensive patients, the MCRDS increased in linear fashion throughout pregnancy. |
| TextSentencer_T6 |
368-507 |
Sentence |
denotes |
In patients with chronic essential hypertension the MCRDS also increased progressively, but at higher values than in normotensive subjects. |
| TextSentencer_T7 |
508-795 |
Sentence |
denotes |
In normotensive gravidas who ultimately developed pregnancy-induced hypertension, the MCRDS increased progressively at a higher level than in gravidas who remained normotensive until approximately 4 weeks prior to the onset of clinical symptoms, at which time the MCRDS slowly decreased. |
| TextSentencer_T8 |
796-1085 |
Sentence |
denotes |
Similarly, in gravidas with chronic hypertension who developed superimposed pregnancy-induced hypertension, the MCRDS increased progressively at higher levels than all groups studied until approximately 4 weeks prior to onset of hypertension, when a progressive decline in the MCRDS began. |
| T1 |
0-59 |
Sentence |
denotes |
Metabolic clearance rate of dehydroisoandrosterone sulfate. |
| T2 |
60-62 |
Sentence |
denotes |
V. |
| T3 |
63-120 |
Sentence |
denotes |
Studies of essential hypertension complicating pregnancy. |
| T4 |
121-281 |
Sentence |
denotes |
The metabolic clearance rate of dehydroisoandrosterone sulfate (MCRDS) was determined prospectively in gravidas with and without chronic essential hypertension. |
| T5 |
282-367 |
Sentence |
denotes |
In normotensive patients, the MCRDS increased in linear fashion throughout pregnancy. |
| T6 |
368-507 |
Sentence |
denotes |
In patients with chronic essential hypertension the MCRDS also increased progressively, but at higher values than in normotensive subjects. |
| T7 |
508-795 |
Sentence |
denotes |
In normotensive gravidas who ultimately developed pregnancy-induced hypertension, the MCRDS increased progressively at a higher level than in gravidas who remained normotensive until approximately 4 weeks prior to the onset of clinical symptoms, at which time the MCRDS slowly decreased. |
| T8 |
796-1085 |
Sentence |
denotes |
Similarly, in gravidas with chronic hypertension who developed superimposed pregnancy-induced hypertension, the MCRDS increased progressively at higher levels than all groups studied until approximately 4 weeks prior to onset of hypertension, when a progressive decline in the MCRDS began. |